ESGENA Scientific Secretary, Ulm, Germany.
Grevenbroich, Germany.
Endoscopy. 2017 Nov;49(11):1098-1106. doi: 10.1055/s-0043-120523. Epub 2017 Oct 16.
Patients should be informed about the benefits and risks of endoscopic retrograde cholangiopancreatography (ERCP)Only specially trained and competent personnel should carry out endoscope reprocessing.Manufacturers of duodenoscopes should provide detailed instructions on how to use and reprocess their equipment.In the case of modifications to their equipment, manufacturers should provide updated instructions for use.Detailed reprocessing protocols based on the manufacturer's instructions for use should clearly lay out the different reprocessing steps necessary for each endoscope model.Appropriate cleaning equipment should be used for duodenoscopes in compliance with the manufacturer's instructions for use. Only purpose-designed, endoscope type-specific, single-use cleaning brushes should be used, to ensure optimal cleaning. As soon as the endoscope is withdrawn from the patient, bedside cleaning should be performed, followed by leak testing, thorough manual cleaning steps, and automated reprocessing, in order to: · Remove debris from external and internal surfaces;. · Prevent any drying of body fluids, blood, or debris;. · Prevent any formation of biofilms.. In addition to the leak test, visual inspection of the distal end as well as regular maintenance of duodenoscopes should be performed according to the manufacturer's instructions for use, in order to detect any damage at an early stage.The entire reprocessing procedure in endoscope washer-disinfectors (EWDs) should be validated according to the European and International Standard, EN ISO 15883. Routine technical tests of EWDs should be performed according to the validation reports.Microbiological surveillance of a proportion of the department's endoscopes should be performed every 3 months, with the requirement that all endoscopes used in the unit are tested at least once a year.In the case of suspected endoscopy-related infection, the relevant device (e. g., endoscope, EWD) should be taken out of service until adequate corrective actions have been taken. Outbreaks should be managed by a multidisciplinary team, including endoscopy, hygiene, and microbiology experts, manufacturers, and regulatory bodies, according to national standards and/or laws. In the case of suspected multidrug-resistant organism (MDRO) outbreaks, close cooperation between the endoscopy unit and the clinical health provider is essential (including infection control departments and hospital hygienists).
患者应当被告知内镜逆行胰胆管造影术(ERCP)的获益和风险。 只有经过专门培训且有能力的人员才能进行内镜处理。 十二指肠镜制造商应提供如何使用和处理其设备的详细说明。 如果设备发生更改,制造商应提供最新的使用说明。 详细的处理方案应根据制造商的使用说明,明确列出每种内镜型号所需的不同处理步骤。 应根据制造商的使用说明使用适当的清洁设备。 仅可使用符合制造商使用说明的专门设计、内镜专用、一次性使用的清洁刷,以确保最佳清洁效果。 内镜从患者体内撤出后,应立即进行床边清洁,然后进行泄漏测试、彻底的手动清洁步骤和自动化处理,以:
从内外表面清除碎屑;
防止体液、血液或碎屑变干;
防止生物膜形成。
除了泄漏测试外,还应根据制造商的使用说明定期进行内镜的目视检查和维护,以尽早发现任何损坏。 整个内镜清洗消毒器(EWD)处理过程应根据欧洲和国际标准 EN ISO 15883 进行验证。 应根据验证报告定期对 EWD 进行技术常规测试。
应每 3 个月对科室的一部分内镜进行微生物监测,要求该科室使用的所有内镜每年至少检测一次。 在怀疑与内镜相关的感染时,应将相关器械(如内镜、EWD)停用,直至采取适当的纠正措施。 应根据国家标准和/或法规,由多学科团队(包括内镜、卫生和微生物学专家、制造商和监管机构)管理暴发。 在怀疑发生多药耐药菌(MDRO)暴发时,内镜科室与临床卫生提供者之间必须密切合作(包括感染控制部门和医院卫生员)。